DARA TUCKER: Open Payments
NPI 1093309536 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,050 in 37 payments from 18 companies in 2025. Trend: 2023 $647 · 2024 $930 · 2025 $1,050
Food & beverage: $1,050
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $207 |
| Fresenius USA Marketing, Inc. | 7 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $148 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Vifor Pharma, Inc. | 2 | $42 |
| Alexion Pharmaceuticals, Inc. | 2 | $38 |
| Ardelyx, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| Travere Therapeutics, Inc. | 1 | $30 |
Products named: VELPHORO, JARDIANCE, FARXIGA, Kerendia, Veltassa, ULTOMIRIS, IBSRELA, TAVNEOS.
Industry payments across KY — which companies pay providers there.
